NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $277,306 | -62.0% | 14,428 | -49.8% | 0.00% | -75.0% |
Q2 2023 | $730,240 | -62.3% | 28,727 | -46.3% | 0.00% | -60.0% |
Q1 2023 | $1,935,435 | -16.8% | 53,539 | -8.8% | 0.01% | -23.1% |
Q4 2022 | $2,325,272 | +92.8% | 58,719 | +127.0% | 0.01% | +62.5% |
Q3 2022 | $1,206,000 | +10.6% | 25,870 | +4.0% | 0.01% | +14.3% |
Q2 2022 | $1,090,000 | -35.6% | 24,873 | +6.3% | 0.01% | -12.5% |
Q1 2022 | $1,692,000 | – | 23,394 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |